Developer docs
API playgroundTry for free, no card

Search company profiles

Clusterbusters

Full company profile

uuid000pwgz

Namestring
Clusterbusters
Legal namestring
Clusterbusters, Inc.
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Clusterbusters, Inc. is a 501(c)(3) non-profit research and educational organization founded in 2002 by Bob Wold and headquartered in Lombard, Illinois. It is the largest cluster headache patient advocacy organization in the world, serving individuals suffering from cluster headaches ('clusterheads'), their caregivers and family members, and the healthcare providers who treat them. The organization runs a comprehensive resource ecosystem including an online patient forum with 39.4k posts, virtual and in-person support groups, a peer-to-peer ClusterBuddies program, an annual U.S. patient conference (now in its 21st year), a video resource library, suicide prevention resources, and the CHAT-III algorithm-based diagnostic tool.

The organization's core activities span patient education, research facilitation, and policy advocacy. Clusterbusters pioneered research into psychedelic treatments (psilocybin, LSD, Bromo-LSD) for cluster headaches, maintaining longstanding research partnerships with Harvard Medical School, Yale School of Medicine, Hannover Medical School, McGill University, and the University of West Georgia. It operates a patient registry that enables clinical trial recruitment, notably contributing to Eli Lilly's CGRP antibody trials that led to FDA approval of Emgality for episodic cluster headache. The organization also advocates for treatment access, including a two-decade effort that culminated in CMS coverage of home oxygen therapy for cluster headache patients in 2021.

Clusterbusters generates no commercial revenue and is funded entirely by tax-deductible donations from individuals, philanthropic supporters, and a small set of pharmaceutical donors including Eli Lilly and Amneal. The organization employs 11–50 staff and operates with a lean team supplemented by a credentialed Medical Advisory Board drawn from leading academic headache centers. Its go-to-market is community-led, relying on patient word-of-mouth, organic social media, forums, and event-driven engagement rather than any commercial sales motion. The organization does not sell products or services; all resources, education, and advocacy are provided free of charge to cluster headache patients and their families.

Short descriptiontext

Clusterbusters is a 501(c)(3) non-profit founded in 2002 and the largest cluster headache patient advocacy organization in the world, serving cluster headache patients, caregivers, and healthcare providers through education, research facilitation, community support, and policy advocacy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLombard, United States
HQ citystring
Lombard
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy services, cluster headache research, neurological disorder support, clinical trial recruitment, patient education resources
Industry2 codes
PRIMARYHLAEAHAK
Behavioral Health Crisis Services Management (988/Hotlines/Mobile Crisis Coordination)
SECONDARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Other Individual and Family Services624190
  • Individual and Family Services6241
SIC code2 codes
  • Services-Social Services8300
  • Services-Health Services8000
Product category
Patient Advocacy Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Charitable Contributions
TypeGrants Donations
Description

As an IRS-approved 501(c)(3) non-profit organization, Clusterbusters relies entirely on donations from individuals, supporters, and pharmaceutical companies (Eli Lilly, Amneal) to fund operations, research, education, advocacy programs, and patient support activities. Donations are tax-deductible and can be made via PayPal, credit/debit card, Zelle, check, or iGive online shopping contributions.

clusterbusters.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Clusterbusters provides cluster headache patients with educational resources, peer support, treatment guidance (including high-flow oxygen therapy and psychedelic treatment research summaries), and clinical trial connections through patient forums, virtual and in-person support groups, and an annual patient conference. The organization also maintains the CHAT-III diagnostic tool, a research studies platform, a patient registry for clinical trial recruitment, and a suicide prevention resource library, and conducts advocacy to expand treatment access (e.g., CMS oxygen coverage).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 69% of cluster headache patients experience suicidal thoughts during attacks; 20x national average suicide attempts
+3 more records
Product overview1 text field

Clusterbusters is a 501(c)(3) nonprofit patient advocacy organization founded in 2002, offering a suite of resources for cluster headache patients. The core offerings include patient forums for community support, a research studies platform connecting patients with clinical trials, the CHAT-III diagnostic tool for headache assessment, and an annual patient conference. Supporting services include virtual support groups and the ClusterBuddies peer-to-peer program, treatment resources covering preventive, abortive, and alternative approaches, a high-flow oxygen therapy guide, a video resource library, and suicide prevention resources. The organization primarily focuses on education, advocacy, and research support rather than a unified technology product.

Product and service9 records
1Patient Forums
CategoryCommunity Platform
Description

Online forums providing a secure community space for cluster headache patients to discuss medications, side effects, alternative treatments, and coping strategies. Includes topic categories for general discussion, advocacy, research news, and migraine-related information.

2Research Studies Platform
CategoryResearch Portal
Description

A platform connecting patients with clinical trials and research studies for cluster headaches, including current and closed studies on topics such as psilocybin, oxygen therapy, genetics, and preventive treatments. Features a patient registry for enrollment.

3CHAT-III Diagnostic Tool
CategoryHealthcare Assessment Tool
Description

The Computerized Headache Assessment Tool (CHAT-III) is an algorithm-based online diagnostic tool developed to help recognize primary headache diseases including migraine, tension-type headache, and cluster headache. Refined with Clusterbusters' assistance for accurate cluster headache recognition.

4Annual Patient Conference
CategoryEvent Program
Description

Annual U.S. patient conference bringing together cluster headache patients, families, and healthcare professionals for support, education, and community. Features emerging treatments, personal testimonies, group support sessions, and CME opportunities for medical professionals.

5Virtual Support Groups
CategorySupport Service
Description

Virtual support groups including patient support groups (meeting monthly on various days/times) and care partner support groups. Includes a peer-to-peer ClusterBuddies program connecting support-seekers with experienced clusterhead volunteers.

6Treatment Options Resource
CategoryEducational Resource
Description

Comprehensive information on cluster headache treatments organized by category: preventive treatments, abortive treatments, and alternative treatments including oxygen therapy, psilocybin, and other tryptamine-based approaches.

7High-Flow Oxygen Therapy Guide
CategoryTreatment Resource
Description

Detailed resource on oxygen therapy for cluster headaches covering equipment (tanks, regulators, masks), flow rates, breathing techniques, prescriptions, insurance navigation, and travel considerations.

8Video Resource Library
CategoryEducational Content
Description

Video gallery featuring educational content including oxygen usage demonstrations, psilocybin treatment discussions, patient testimonies, medical professional presentations, and advocacy event recordings.

9Suicide Prevention Resources
CategoryCrisis Support Service
Description

Comprehensive suicide prevention and crisis intervention resources specifically tailored for cluster headache patients, including international hotlines, coping strategies, and support for those experiencing suicidal thoughts during attacks.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
1Harvard Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters worked with Harvard in the early 2000s on psychedelic research, which showed how useful psilocybin compounds could be in decreasing not only attack frequency but the intensity of pain, allowing chronic patients to become episodic and get up to two years or more of pain-free time.

clusterbusters.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters has worked with Yale to continue research into psilocybin for cluster headache treatment. Dr. Emmanuelle Schindler at Yale executed the first controlled trials investigating psilocybin effects in cluster headache. Dr. Christopher Gottschalk continues the psilocybin research project started by Andrew Sewell.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters collaborated with Hannover Medical School in Germany and Professor Torsten Passie to study LSD, psilocybin, and Bromo-LSD (BOL-148) for cluster headache treatment, including research into non-hallucinogenic compounds.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters has collaborated with McGill University on cluster headache research projects.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

With Dr. Larry Schor at University of West Georgia, Clusterbusters completed the largest survey ever conducted to establish the severity and burden of cluster headaches (CHQ).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters has branched out to include work with the VA on various impacts of cluster headaches, including the Oxygen Interview Study at VA Connecticut Healthcare System.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters has collaborated with Children's Hospital on research into various impacts of cluster headaches.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters is a proud member organization of AHDA. An alliance of headache organizations that advocate for all people suffering from headache disorders with a united voice. Annual trip to Washington DC to educate and advocate for increased research funding and improved treatment.

9Coalition for Headache And Migraine Patients (CHAMP)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHAMP brings many headache and migraine organizations together for a common goal of improving lives. Clusterbusters is a proud partner, participating in events like annual Retreat Migraine and multiple headache-related conferences.

clusterbusters.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

HMPF is dedicated to advancing public policy and practices to improve treatment access. Clusterbusters has partnered with HMPF which plays a critical role in annual Headache on the Hill event.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters works with AHS, with Executive Director Bob Wold presenting at AHS conferences and events.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters joined the American Migraine Foundation to fight debilitating head pain together as part of ongoing commitment to providing meaningful information, resources and support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clusterbusters is a proud member organization with NORD as they partner to overcome challenges of rare disorder representation and collective voice.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters is affiliated with NHF as part of their network of headache and migraine organizations.

15Headache Cooperative of New England (HCNE)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters works with HCNE, including participation in their conferences where patients have presented alongside medical professionals.

clusterbusters.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters is affiliated with U.S. Pain Foundation as part of the broader pain advocacy community.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters participates in Migraine World Summit events and collaborations.

18Organisation for the Understanding Cluster Headache in the UK (OUCH-UK)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clusterbusters is connected with OUCH-UK, the UK-based organization for understanding cluster headache.

clusterbusters.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Lobe Sciences Ltd. and Cynaptec Pharmaceuticals will present a new therapeutic approach for treating chronic cluster headaches at Clusterbusters 2025 conference.

20Cynaptec Pharmaceuticals, Inc.
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cynaptec Pharmaceuticals, Inc. will present a new therapeutic approach for treating chronic cluster headaches at Clusterbusters 2025 conference alongside Lobe Sciences Ltd.

clusterbusters.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Coalition for Headache And Migraine Patients (CHAMP)
TypeDirect peer
Description

CHAMP is a coalition of headache and migraine patient organizations working collectively on advocacy and education. Clusterbusters is a proud partner of CHAMP and both organizations co-host events like Retreat Migraine, making CHAMP a direct peer in coalition-based headache patient advocacy.

TypeBroad incumbent
Description

NORD is a broad incumbent umbrella for rare disease patient organizations, providing advocacy, research funding, and coalition support. Clusterbusters is a member organization with NORD, and NORD plays a similar role at a much larger scale across thousands of rare conditions.

TypeDirect peer
Description

The American Migraine Foundation is a patient-focused nonprofit supporting migraine research and education. Clusterbusters is an active partner of the AMF, and AMF runs a parallel playbook of patient education, research facilitation, and physician resources — making it a direct peer in the headache advocacy space.

TypeBroad incumbent
Description

The U.S. Pain Foundation is a broader pain advocacy nonprofit providing education, support, and policy advocacy across multiple pain conditions including headache. Clusterbusters is affiliated with the U.S. Pain Foundation, making it a broad incumbent peer in pain patient advocacy.

TypeBroad incumbent
Description

The American Headache Society is the professional society for clinicians treating headache disorders. Clusterbusters partners with AHS and presents at its conferences, making AHS a broad incumbent peer that bridges the patient and clinician sides of headache care.

TypeDirect peer
Description

HMPF is a dedicated policy and advocacy organization focused on advancing public policy for headache treatment access. Clusterbusters partners with HMPF on Headache on the Hill, making it a direct peer in headache-specific policy advocacy.

7OUCH UK (Organisation for the Understanding of Cluster Headache)
TypeRegional player
Description

OUCH UK is the UK-based counterpart cluster headache patient organization focused on the same rare condition. Clusterbusters is connected with OUCH-UK as an international peer, and OUCH-UK provides parallel advocacy, support, and education in the UK geography.

TypeDirect peer
Description

The Migraine Research Foundation is a nonprofit that funds migraine and headache research and provides patient education. It shares Clusterbusters' focus on research grants, education, and patient resources within the headache disorder space.

TypeDirect peer
Description

The National Headache Foundation is a long-established nonprofit dedicated to headache education, research funding, and patient support. It is an affiliate of Clusterbusters and addresses a broader headache population with similar advocacy, education, and research grantmaking activities — the closest direct peer in mission and structure.

TypeDirect peer
Description

AHDA is an alliance of headache organizations that advocates collectively for increased research funding and improved treatment access, including the annual Headache on the Hill event. Clusterbusters is a member organization, making AHDA a direct peer in federal policy advocacy for headache disorders.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clusterbusters

Patient Advocacy Servicesclusterbusters.org

Clusterbusters is a 501(c)(3) non-profit founded in 2002 and the largest cluster headache patient advocacy organization in the world, serving cluster headache patients, caregivers, and healthcare providers through education, research facilitation, community support, and policy advocacy.

What Clusterbusters does

Clusterbusters, Inc. is a 501(c)(3) non-profit research and educational organization founded in 2002 by Bob Wold and headquartered in Lombard, Illinois. It is the largest cluster headache patient advocacy organization in the world, serving individuals suffering from cluster headaches ('clusterheads'), their caregivers and family members, and the healthcare providers who treat them. The organization runs a comprehensive resource ecosystem including an online patient forum with 39.4k posts, virtual and in-person support groups, a peer-to-peer ClusterBuddies program, an annual U.S. patient conference (now in its 21st year), a video resource library, suicide prevention resources, and the CHAT-III algorithm-based diagnostic tool.

The organization's core activities span patient education, research facilitation, and policy advocacy. Clusterbusters pioneered research into psychedelic treatments (psilocybin, LSD, Bromo-LSD) for cluster headaches, maintaining longstanding research partnerships with Harvard Medical School, Yale School of Medicine, Hannover Medical School, McGill University, and the University of West Georgia. It operates a patient registry that enables clinical trial recruitment, notably contributing to Eli Lilly's CGRP antibody trials that led to FDA approval of Emgality for episodic cluster headache. The organization also advocates for treatment access, including a two-decade effort that culminated in CMS coverage of home oxygen therapy for cluster headache patients in 2021.

Clusterbusters generates no commercial revenue and is funded entirely by tax-deductible donations from individuals, philanthropic supporters, and a small set of pharmaceutical donors including Eli Lilly and Amneal. The organization employs 11–50 staff and operates with a lean team supplemented by a credentialed Medical Advisory Board drawn from leading academic headache centers. Its go-to-market is community-led, relying on patient word-of-mouth, organic social media, forums, and event-driven engagement rather than any commercial sales motion. The organization does not sell products or services; all resources, education, and advocacy are provided free of charge to cluster headache patients and their families.

Clusterbusters firmographics

Firmographics
Name
Clusterbusters
Legal name
Clusterbusters, Inc.
Website
https://clusterbusters.org
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
1–10 employees
Short description
Clusterbusters is a 501(c)(3) non-profit founded in 2002 and the largest cluster headache patient advocacy organization in the world, serving cluster headache patients, caregivers, and healthcare providers through education, research facilitation, community support, and policy advocacy.
Ownership category
akta.pro rank

Clusterbusters industry classification

Industry
Product category
Patient Advocacy Services
NAICS
Other Individual and Family Services (624190), Individual and Family Services (6241)
SIC
Services-Social Services (8300), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAEAHAK
Behavioral Health Crisis Services Management (988/Hotlines/Mobile Crisis Coordination)
SECONDARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Patient advocacy services
  • Cluster headache research
  • Neurological disorder support
  • Clinical trial recruitment
  • Patient education resources

Where Clusterbusters is headquartered

Location

Headquarters

HQ city
Lombard
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Clusterbusters business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations and Charitable Contributions: As an IRS-approved 501(c)(3) non-profit organization, Clusterbusters relies entirely on donations from individuals, supporters, and pharmaceutical companies (Eli Lilly, Amneal) to fund operations, research, education, advocacy programs, and patient support activities. Donations are tax-deductible and can be made via PayPal, credit/debit card, Zelle, check, or iGive online shopping contributions.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Clusterbusters product offering

Product offering

Core offering

Clusterbusters provides cluster headache patients with educational resources, peer support, treatment guidance (including high-flow oxygen therapy and psychedelic treatment research summaries), and clinical trial connections through patient forums, virtual and in-person support groups, and an annual patient conference. The organization also maintains the CHAT-III diagnostic tool, a research studies platform, a patient registry for clinical trial recruitment, and a suicide prevention resource library, and conducts advocacy to expand treatment access (e.g., CMS oxygen coverage).

Product overview

Clusterbusters is a 501(c)(3) nonprofit patient advocacy organization founded in 2002, offering a suite of resources for cluster headache patients. The core offerings include patient forums for community support, a research studies platform connecting patients with clinical trials, the CHAT-III diagnostic tool for headache assessment, and an annual patient conference. Supporting services include virtual support groups and the ClusterBuddies peer-to-peer program, treatment resources covering preventive, abortive, and alternative approaches, a high-flow oxygen therapy guide, a video resource library, and suicide prevention resources. The organization primarily focuses on education, advocacy, and research support rather than a unified technology product.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Forums Online forums providing a secure community space for cluster headache patients to discuss medications, side effects, alternative treatments, and coping strategies. Includes topic categories for general discussion, advocacy, research news, and migraine-related information.
  • Research Studies Platform A platform connecting patients with clinical trials and research studies for cluster headaches, including current and closed studies on topics such as psilocybin, oxygen therapy, genetics, and preventive treatments. Features a patient registry for enrollment.
  • CHAT-III Diagnostic Tool The Computerized Headache Assessment Tool (CHAT-III) is an algorithm-based online diagnostic tool developed to help recognize primary headache diseases including migraine, tension-type headache, and cluster headache. Refined with Clusterbusters' assistance for accurate cluster headache recognition.
  • Annual Patient Conference Annual U.S. patient conference bringing together cluster headache patients, families, and healthcare professionals for support, education, and community. Features emerging treatments, personal testimonies, group support sessions, and CME opportunities for medical professionals.
  • Virtual Support Groups Virtual support groups including patient support groups (meeting monthly on various days/times) and care partner support groups. Includes a peer-to-peer ClusterBuddies program connecting support-seekers with experienced clusterhead volunteers.
  • Treatment Options Resource Comprehensive information on cluster headache treatments organized by category: preventive treatments, abortive treatments, and alternative treatments including oxygen therapy, psilocybin, and other tryptamine-based approaches.
  • High-Flow Oxygen Therapy Guide Detailed resource on oxygen therapy for cluster headaches covering equipment (tanks, regulators, masks), flow rates, breathing techniques, prescriptions, insurance navigation, and travel considerations.
  • Video Resource Library Video gallery featuring educational content including oxygen usage demonstrations, psilocybin treatment discussions, patient testimonies, medical professional presentations, and advocacy event recordings.
  • Suicide Prevention Resources Comprehensive suicide prevention and crisis intervention resources specifically tailored for cluster headache patients, including international hotlines, coping strategies, and support for those experiencing suicidal thoughts during attacks.

Quantifiable outcome

  • 69% of cluster headache patients experience suicidal thoughts during attacks; 20x national average suicide attempts
  • +3 more outcomes

Companies that use Clusterbusters

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Clusterbusters technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Clusterbusters partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and minor.

  • Harvard Medical SchoolcoreStrategic or Co-development PartnerClusterbusters worked with Harvard in the early 2000s on psychedelic research, which showed how useful psilocybin compounds could be in decreasing not only attack frequency but the intensity of pain, allowing chronic patients to become episodic and get up to two years or more of pain-free time.
  • Yale School of MedicinecoreStrategic or Co-development PartnerClusterbusters has worked with Yale to continue research into psilocybin for cluster headache treatment. Dr. Emmanuelle Schindler at Yale executed the first controlled trials investigating psilocybin effects in cluster headache. Dr. Christopher Gottschalk continues the psilocybin research project started by Andrew Sewell.
  • Hannover Medical School (Germany)coreStrategic or Co-development PartnerClusterbusters collaborated with Hannover Medical School in Germany and Professor Torsten Passie to study LSD, psilocybin, and Bromo-LSD (BOL-148) for cluster headache treatment, including research into non-hallucinogenic compounds.
  • McGill UniversityminorStrategic or Co-development PartnerClusterbusters has collaborated with McGill University on cluster headache research projects.
  • University of West GeorgiaminorStrategic or Co-development PartnerWith Dr. Larry Schor at University of West Georgia, Clusterbusters completed the largest survey ever conducted to establish the severity and burden of cluster headaches (CHQ).
  • Veterans Administration (VA)minorStrategic or Co-development PartnerClusterbusters has branched out to include work with the VA on various impacts of cluster headaches, including the Oxygen Interview Study at VA Connecticut Healthcare System.
  • Children's HospitalminorStrategic or Co-development PartnerClusterbusters has collaborated with Children's Hospital on research into various impacts of cluster headaches.
  • Alliance for Headache Disorders Advocacy (AHDA)coreStrategic or Co-development PartnerClusterbusters is a proud member organization of AHDA. An alliance of headache organizations that advocate for all people suffering from headache disorders with a united voice. Annual trip to Washington DC to educate and advocate for increased research funding and improved treatment.
  • Coalition for Headache And Migraine Patients (CHAMP)coreStrategic or Co-development PartnerCHAMP brings many headache and migraine organizations together for a common goal of improving lives. Clusterbusters is a proud partner, participating in events like annual Retreat Migraine and multiple headache-related conferences.
  • Headache & Migraine Policy Forum (HMPF)coreStrategic or Co-development PartnerHMPF is dedicated to advancing public policy and practices to improve treatment access. Clusterbusters has partnered with HMPF which plays a critical role in annual Headache on the Hill event.
  • American Headache Society (AHS)coreStrategic or Co-development PartnerClusterbusters works with AHS, with Executive Director Bob Wold presenting at AHS conferences and events.
  • American Migraine FoundationcoreStrategic or Co-development PartnerClusterbusters joined the American Migraine Foundation to fight debilitating head pain together as part of ongoing commitment to providing meaningful information, resources and support.
  • National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerClusterbusters is a proud member organization with NORD as they partner to overcome challenges of rare disorder representation and collective voice.
  • National Headache Foundation (NHF)minorStrategic or Co-development PartnerClusterbusters is affiliated with NHF as part of their network of headache and migraine organizations.
  • Headache Cooperative of New England (HCNE)minorStrategic or Co-development PartnerClusterbusters works with HCNE, including participation in their conferences where patients have presented alongside medical professionals.
  • U.S. Pain FoundationminorStrategic or Co-development PartnerClusterbusters is affiliated with U.S. Pain Foundation as part of the broader pain advocacy community.
  • Migraine World SummitminorStrategic or Co-development PartnerClusterbusters participates in Migraine World Summit events and collaborations.
  • Organisation for the Understanding Cluster Headache in the UK (OUCH-UK)minorStrategic or Co-development PartnerClusterbusters is connected with OUCH-UK, the UK-based organization for understanding cluster headache.
  • Lobe Sciences Ltd.minorStrategic or Co-development PartnerLobe Sciences Ltd. and Cynaptec Pharmaceuticals will present a new therapeutic approach for treating chronic cluster headaches at Clusterbusters 2025 conference.
  • Cynaptec Pharmaceuticals, Inc.minorStrategic or Co-development PartnerCynaptec Pharmaceuticals, Inc. will present a new therapeutic approach for treating chronic cluster headaches at Clusterbusters 2025 conference alongside Lobe Sciences Ltd.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Clusterbusters competitors and assessment

Company assessment

Direct peers

  • Coalition for Headache And Migraine Patients (CHAMP): CHAMP is a coalition of headache and migraine patient organizations working collectively on advocacy and education. Clusterbusters is a proud partner of CHAMP and both organizations co-host events like Retreat Migraine, making CHAMP a direct peer in coalition-based headache patient advocacy.
  • American Migraine Foundation: The American Migraine Foundation is a patient-focused nonprofit supporting migraine research and education. Clusterbusters is an active partner of the AMF, and AMF runs a parallel playbook of patient education, research facilitation, and physician resources — making it a direct peer in the headache advocacy space.
  • Headache & Migraine Policy Forum (HMPF): HMPF is a dedicated policy and advocacy organization focused on advancing public policy for headache treatment access. Clusterbusters partners with HMPF on Headache on the Hill, making it a direct peer in headache-specific policy advocacy.
  • Migraine Research Foundation: The Migraine Research Foundation is a nonprofit that funds migraine and headache research and provides patient education. It shares Clusterbusters' focus on research grants, education, and patient resources within the headache disorder space.
  • National Headache Foundation: The National Headache Foundation is a long-established nonprofit dedicated to headache education, research funding, and patient support. It is an affiliate of Clusterbusters and addresses a broader headache population with similar advocacy, education, and research grantmaking activities — the closest direct peer in mission and structure.
  • Alliance for Headache Disorders Advocacy (AHDA): AHDA is an alliance of headache organizations that advocates collectively for increased research funding and improved treatment access, including the annual Headache on the Hill event. Clusterbusters is a member organization, making AHDA a direct peer in federal policy advocacy for headache disorders.

Broad incumbents

  • National Organization for Rare Disorders (NORD): NORD is a broad incumbent umbrella for rare disease patient organizations, providing advocacy, research funding, and coalition support. Clusterbusters is a member organization with NORD, and NORD plays a similar role at a much larger scale across thousands of rare conditions.
  • U.S. Pain Foundation: The U.S. Pain Foundation is a broader pain advocacy nonprofit providing education, support, and policy advocacy across multiple pain conditions including headache. Clusterbusters is affiliated with the U.S. Pain Foundation, making it a broad incumbent peer in pain patient advocacy.
  • American Headache Society: The American Headache Society is the professional society for clinicians treating headache disorders. Clusterbusters partners with AHS and presents at its conferences, making AHS a broad incumbent peer that bridges the patient and clinician sides of headache care.

Regional players

  • OUCH UK (Organisation for the Understanding of Cluster Headache): OUCH UK is the UK-based counterpart cluster headache patient organization focused on the same rare condition. Clusterbusters is connected with OUCH-UK as an international peer, and OUCH-UK provides parallel advocacy, support, and education in the UK geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Clusterbusters social profiles

Digital presence

Clusterbusters financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clusterbusters leadership team

Management profile

Number of profiles

Profiles12 records

Clusterbusters funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clusterbusters M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clusterbusters

What does Clusterbusters do?

Clusterbusters provides cluster headache patients with educational resources, peer support, treatment guidance (including high-flow oxygen therapy and psychedelic treatment research summaries), and clinical trial connections through patient forums, virtual and in-person support groups, and an annual patient conference. The organization also maintains the CHAT-III diagnostic tool, a research studies platform, a patient registry for clinical trial recruitment, and a suicide prevention resource library, and conducts advocacy to expand treatment access (e.g., CMS oxygen coverage).

Is Clusterbusters a public or private company?

Clusterbusters is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Clusterbusters founded?

Clusterbusters was founded in 2002. It employs 1 to 10 people.

Where is Clusterbusters based?

Clusterbusters is headquartered in Lombard, United States, in the North America region.

How does Clusterbusters make money?

One revenue line is on record: donations and Charitable Contributions.

Who are Clusterbusters's main competitors?

Direct peers on record are Coalition for Headache And Migraine Patients (CHAMP), American Migraine Foundation, Headache & Migraine Policy Forum (HMPF), Migraine Research Foundation, National Headache Foundation and Alliance for Headache Disorders Advocacy (AHDA). Broad incumbents are National Organization for Rare Disorders (NORD), U.S. Pain Foundation and American Headache Society. OUCH UK (Organisation for the Understanding of Cluster Headache) is listed as a regional player.

Does Clusterbusters have an API?

No public API is recorded for Clusterbusters.

What industry is Clusterbusters in?

Clusterbusters's product category is Patient Advocacy Services. Its primary akta.pro industry code is HLAEAHAK, Behavioral Health Crisis Services Management (988/Hotlines/Mobile Crisis Coordination), with a secondary code of HLACAFAD, Behavioral Health & Substance Use Remote Monitoring. Its NAICS code is 624190 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales